Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryutaro Uchi

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Auris, Nasus, Larynx|July 26, 2017
The treatment and outcome analysis of primary squamous cell carcinoma of the thyroidRyuji Yasumatsu, Masanobu Sato, Ryutaro Uchi, et al.
Acta Oto-Laryngologica|August 19, 2020
Clinical outcome in recurrent and/or metastatic head and neck cancer patients after discontinuation of nivolumab monotherapy due to immune-related adverse eventsRyuji Yasumatsu, Mioko Matsuo, Takahiro Wakasaki, et al.
The Annals of Otology, Rhinology, and Laryngology|June 5, 2019
Small Cell Carcinoma in the Head and NeckTakahiro Wakasaki, Ryuji Yasumatsu, Muneyuki Masuda, et al.
Anticancer Research|January 9, 2021
Genomic Sequencing of Cancer-related Genes in Sinonasal Squamous Cell Carcinoma and Coexisting Inverted PapillomaRyutaro Uchi, Rina Jiromaru, Ryuji Yasumatsu, et al.
Oral Oncology|December 28, 2020
Drug-induced interstitial lung disease in recurrent and/or metastatic head and neck cancer patients treated with cetuximab and/or nivolumabMioko Matsuo, Ryuji Yasumatsu, Muneyuki Masuda, et al.
Cancers|August 23, 2020
Prognostic Biomarkers of Salvage Chemotherapy Following Nivolumab Treatment for Recurrent and/or Metastatic Head and Neck Squamous Cell CarcinomaTakahiro Wakasaki, Ryuji Yasumatsu, Muneyuki Masuda, et al.
FEBS Open Bio|June 11, 2021
Establishment and characterization of a primary cell culture derived from external auditory canal squamous cell carcinomaYuki Sekino, Akira Imaizumi, Noritaka Komune, et al.
Auris, Nasus, Larynx|May 25, 2020
Therapeutic effect of Nivolumab for advanced / recurrent temporal bone squamous cell carcinomaTeppei Noda, Noritaka Komune, Ryuji Yasumatsu, et al.
Journal of Neurological Surgery. Part B, Skull Base|July 14, 2022
Clinical Analysis of En Bloc Resection for Advanced Temporal Bone Squamous Cell CarcinomaNoritaka Komune, Daisuke Kuga, Satoshi Matsuo, et al.
Frontiers in Oncology|August 28, 2020
Prognostic Impact of Tumor Extension in Patients With Advanced Temporal Bone Squamous Cell CarcinomaNoritaka Komune, Masaru Miyazaki, Kuniaki Sato, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Auris, Nasus, Larynx|July 26, 2017
The treatment and outcome analysis of primary squamous cell carcinoma of the thyroidRyuji Yasumatsu, Masanobu Sato, Ryutaro Uchi, et al.
Acta Oto-Laryngologica|August 19, 2020
Clinical outcome in recurrent and/or metastatic head and neck cancer patients after discontinuation of nivolumab monotherapy due to immune-related adverse eventsRyuji Yasumatsu, Mioko Matsuo, Takahiro Wakasaki, et al.
The Annals of Otology, Rhinology, and Laryngology|June 5, 2019
Small Cell Carcinoma in the Head and NeckTakahiro Wakasaki, Ryuji Yasumatsu, Muneyuki Masuda, et al.
Anticancer Research|January 9, 2021
Genomic Sequencing of Cancer-related Genes in Sinonasal Squamous Cell Carcinoma and Coexisting Inverted PapillomaRyutaro Uchi, Rina Jiromaru, Ryuji Yasumatsu, et al.
Oral Oncology|December 28, 2020
Drug-induced interstitial lung disease in recurrent and/or metastatic head and neck cancer patients treated with cetuximab and/or nivolumabMioko Matsuo, Ryuji Yasumatsu, Muneyuki Masuda, et al.
Cancers|August 23, 2020
Prognostic Biomarkers of Salvage Chemotherapy Following Nivolumab Treatment for Recurrent and/or Metastatic Head and Neck Squamous Cell CarcinomaTakahiro Wakasaki, Ryuji Yasumatsu, Muneyuki Masuda, et al.
FEBS Open Bio|June 11, 2021
Establishment and characterization of a primary cell culture derived from external auditory canal squamous cell carcinomaYuki Sekino, Akira Imaizumi, Noritaka Komune, et al.
Auris, Nasus, Larynx|May 25, 2020
Therapeutic effect of Nivolumab for advanced / recurrent temporal bone squamous cell carcinomaTeppei Noda, Noritaka Komune, Ryuji Yasumatsu, et al.
Journal of Neurological Surgery. Part B, Skull Base|July 14, 2022
Clinical Analysis of En Bloc Resection for Advanced Temporal Bone Squamous Cell CarcinomaNoritaka Komune, Daisuke Kuga, Satoshi Matsuo, et al.
Frontiers in Oncology|August 28, 2020
Prognostic Impact of Tumor Extension in Patients With Advanced Temporal Bone Squamous Cell CarcinomaNoritaka Komune, Masaru Miyazaki, Kuniaki Sato, et al.
Pageof 7